RecruitingNot ApplicableNCT07605221

Nomogram for Astigmatism Correction of KLEx

Nomogram Optimization for Astigmatism Precision Correction of Corneal Refractive Correction


Sponsor

Tianjin Eye Hospital

Enrollment

100 participants

Start Date

Feb 18, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this clinical trial is to learn if nomogram could promote treatment outcomes in astigmatism correction. The main question it aims to answer is: does the nomogram could promote treatment outcomes in astigmatism correction? If there is a comparison group: Researchers will compare non-nomogram adopted to see if the outcome acceptable. Participants will ask to complete 3-month follow-up of manifest refraction and visual acuity test.


Eligibility

Min Age: 18 YearsMax Age: 45 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called nomogram for people with astigmatism. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREnomogram

nomogram was added to nomogram group


Locations(1)

Tianjin Eye Hospital

Tianjin, Tianjin Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07605221


Related Trials